Coalition for Epidemic Preparedness Innovations

Recent papers from Coalition for Epidemic Preparedness Innovations

1. Delivering Pandemic Vaccines in 100 Days — What Will It Take?New England Journal of Medicine · 2022
2. Summary of 2025 Society of Toxicology Workshop “Vaccine Toxicology in the Post-COVID Era”Vaccine · 2026
3. Systematic exploration of predicted quaternary structures within pandemic-relevant viral proteomes2026
4. Closing the preparedness gap: moving beyond emergency response to sustain the medical countermeasure ecosystemThe Lancet · 2026
5. Marburg virus persistence and clinical complications among recovered persons in Rwanda: a longitudinal study protocolBMJ Open · 2026
6. Lesion viral burden, multidrug-resistant superinfection, and HIV-associated haematological vulnerability in hospitalised clade Ib mpox: a prospective cohort study in UgandaEBioMedicine · 2026
7. Conference report: airway mucosal sampling and immune analysisVaccine · 2026
8. Ethical challenges in outbreak trial design: from Ebola to NipahVaccine · 2026
9. Clinical and microbiological features of critical Clade Ib mpox in adults with HIV during a Ugandan outbreakInternational Journal of Infectious Diseases · 2026
10. Development and Qualification of a Nipah Virus Glycoprotein-Specific IgG ELISA for the Assessment of Human Antibody ResponsesVaccines · 2026
11. Development of a GMMA-based candidate vaccine against invasive nontyphoidal Salmonella diseaseFrontiers in Immunology · 2026
12. Nipah virus destroyed my personal, family, and social life: stories of the hardship faced by Nipah survivors in BangladeshInternational Journal for Equity in Health · 2026
13. Second regulatory workshop on utilising in silico models to expedite vaccine development, testing, and lifecycle management - an expert meeting reportVaccine · 2026
14. A regional coalition for Lassa fever vaccine development and preparedness in West Africa: a practice-based PerspectiveInternational Journal of Infectious Diseases · 2026
15. Alternative approaches to phase III clinical trials for vaccine efficacy and licensure: the role of real-world evidence – a meeting reportBiologicals · 2026
16. Searching for immune correlates in Lassa vaccine development – workshop reportnpj Vaccines · 2026
17. Science-policy translation for Lassa fever control in West Africa: a qualitative synthesis of regional evidence.2026
18. Evaluation of candidate reference materials for the harmonization of Lassa fever serology.2026
19. Feasibility, accuracy, and effect of a rapid point-of-care serological test (SeroSelectTB) to identify presumptive pulmonary TB patients for confirmatory testing in Ethiopia, South Africa, and Tanzania: a multicenter, open-label, parallel-group, randomized, controlled trialEClinicalMedicine · 2026
20. Breaking Down Barriers: A Funder's Perspective on Achieving Equity and Inclusivity in Infectious Disease Modelling and EpidemiologyEpidemics · 2026